Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Melanocortin Type 2 Receptor Antagonists as a New Treatment Modality in Canine Hypercortisolism in vitro Investigation
K. Sanders
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Introduction: Hypercortisolism or Cushing’s syndrome is one of the most common endocrinopathies in dogs. Current medical management options consist of the adrenocorticolytic drug mitotane (o,p`-DDD) or the adrenocorticostatic drug trilostane. Both options are effective, yet both may have side-effects. In pituitary-dependent hypercortisolism (PDH), excess cortisol production is caused by hypersecretion of ACTH, which binds to its receptor, the melanocortin type 2 receptor (MC2R), in the adrenal cortex. Blockage of MC2R could therefore be an interesting treatment target to selectively inhibit cortisol production in PDH.
Aim of the study: To assess the effect of two different MC2R antagonists, BIM-776 (776) and BIM-299 (299), on cortisol production in canine primary adrenocortical cell culture. […]
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
Affiliation of the authors at the time of publication
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
Copyright Statement
© All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.Related Content
Readers also viewed these publications
No related publications found.
Comments (0)
Ask the author
0 comments